This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Steve Saklad
saklad.name
did:plc:sij7wzttoxd3ujhhnptqb3c5
In a non-randomized matched sample of 7K patients, semaglutide or duraglutide was observed to have lower risk than empagliflozin in patients with type 2 diabetes who are at high risk for cardiac events or stroke.
https://www.acpjournals.org/doi/10.7326/ANNALS-24-00775-PS #Medsky
https://www.acpjournals.org/doi/10.7326/ANNALS-24-00775-PS?cmp=1
2025-06-16T22:16:39.451Z